Current Edition

endometriosis

Myovant, Pfizer’s expansion bid for Myfembree hits a snag at the FDA

Myovant and Pfizer’s endometriosis expansion bid for Myfembree has hit a pothole late in the FDA’s review process. In a letter to the companies, the United States …

Continue Reading →